Screening for type 1 diabetes: why is it needed? Virtual event
23.11.21 - 23.11.21
Screening of type 1 diabetes in prone families in relation to autoantibodies can provide an opportunity to educate and prepare families for disease symptoms and prevent Diabetic ketoacidosis (DKA) a dangerous and even death condition. Furthermore, therapeutic interventions under clinical development could significantly delay the onset of T1D and potentially stop the disease from developing at all.
This webinar aims at engaging world leading experts of T1D screening, as well as patients, policy makers and other stakeholders to discuss the inclusion of screenings for pre-symptomatic type 1 diabetes into the standard care service catalogue. Participants will discuss the importance of national screenings for type 1 diabetes, the health economic benefits of screening and the patient perspective.